Tobacco company rebuts its workers' affidavits

Article Abstract:

Philip Morris has denied accusations made by three former workers in affidavits filed with the Food and Drug Administration. The workers accuse the company of conducting hourly tests to measure the nicotine levels in its tobacco, and of boosting nicotine levels in some of its products. In addition, the group Action on Smoking and Health has released a tape of a 1989 meeting of Philip Morris tobacco researchers that the group alleges shows that the researchers knew how to remove some carcinogens from cigarettes.

Smoking, Action on Smoking and Health

---

Close, but no cigar

Article Abstract:

The American Medical Assn responded to the tobacco industry's proposed settlement with a 48-page analysis of the agreement and some suggestions for improvements. The settlement should provide clear FDA authority over tobacco and allow the FDA to eliminate or restrict nicotine levels at any time. Further the settlement should fine tobacco companies $450 million for each percentage point above a target for reducing smoking by minors.

Tobacco farms, Tobacco, Tobacco Farming, American Medical Association

---

Bad deal: big tobacco wants to dodge FDA oversight, and do it on the cheap

Article Abstract:

Philip Morris Inc.'s package of measures to curb the use of tobacco products by underage persons is based on self interest, not altruism. The plan involves several loopholes which would allow the tobacco company protection from oversight by the Food and Drug Administration. For example, Philip Morris is proposing a ban on outdoor advertising near schools in exchange for limited restrictions on other types of ads.

Social policy

Similar abstracts:

• Abstracts: Teaching alternative therapies to diploma nursing students. Its a duet not a duel. A creditable experience
• Abstracts: A lesson in litigation. Learning to understand a patient's silence
• Abstracts: From outcomes research to disease management: a guide for the perplexed. Disease management: new wine in new bottles?
• Abstracts: Triple-drug therapy may boost ovarian cancer survival. Short-term antihypertensive used despite FDA advice. Potentially deadly drug combination still being taken

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.